英国皮肤科医生协会 2021 年成人基底细胞癌治疗指南

2021-05-29 英国皮肤科医师协会 British Journal of Dermatology

20201年5月29日，英国皮肤科医生协会发布2021年成人基底细胞癌治疗指南，该指南的总体目标是为基底细胞癌 (BCC) 的管理提供最新的、基于证据的建议。

中文标题：

英文标题：

British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021

发布机构：

英国皮肤科医师协会

发布日期：

2021-05-29

简要介绍：

20201年5月29日，英国皮肤科医生协会发布2021年成人基底细胞癌治疗指南，该指南的总体目标是为基底细胞癌 (BCC) 的管理提供最新的、基于证据的建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=d76a31c00225e072, title=英国皮肤科医生协会 2021 年成人基底细胞癌治疗指南, enTitle=British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021, guiderFrom=British Journal of Dermatology, authorId=0, author=, summary=20201年5月29日，英国皮肤科医生协会发布2021年成人基底细胞癌治疗指南，该指南的总体目标是为基底细胞癌 (BCC) 的管理提供最新的、基于证据的建议。, cover=https://img.medsci.cn/2021117/1636293528561_1608702.jpg, journalId=0, articlesId=null, associationId=173, associationName=英国皮肤科医师协会, associationIntro=英国皮肤科医师学会（British Association of Dermatologists，BAD）成立于1920年，是一家由英国和爱尔兰皮肤科医生学者组成的专业组织。网站提供大量的临床指南，氨基丙名称分类，并明确标出5年内，5年以上及最近更新，可直接下载。拥有BJD及CED两本期刊。, copyright=0, guiderPublishedTime=Sat May 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=20201年5月29日，英国皮肤科医生协会发布2021年成人基底细胞癌治疗指南，该指南的总体目标是为基底细胞癌 (BCC) 的管理提供最新的、基于证据的建议。, tagList=[TagDto(tagId=1832, tagName=基底细胞癌), TagDto(tagId=117231, tagName=骨及皮肤软组织肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1832, guiderKeyword=基底细胞癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3813, appHits=113, showAppHits=0, pcHits=262, showPcHits=3700, likes=0, shares=65, comments=6, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-05-29, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sun Nov 07 22:02:11 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Tue Jan 02 01:08:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=英国皮肤科医生协会 2021 年成人基底细胞癌治疗指南.pdf)])

英国皮肤科医生协会 2021 年成人基底细胞癌治疗指南.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1195729, encodeId=28ae1195e292c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d5e6514612, createdName=ms7000001627707414, createdTime=Mon Feb 21 16:24:38 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070730, encodeId=5ad410e073015, content=感谢分享，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56095714142, createdName=ms5000000753978789, createdTime=Tue Nov 16 12:24:38 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069348, encodeId=ecc6106934812, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Thu Nov 11 19:41:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068004, encodeId=d0311068004bd, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 08 08:37:43 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
2022-02-21 ms7000001627707414

感谢

44 0
[GetPortalCommentsPageByObjectIdResponse(id=1195729, encodeId=28ae1195e292c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d5e6514612, createdName=ms7000001627707414, createdTime=Mon Feb 21 16:24:38 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070730, encodeId=5ad410e073015, content=感谢分享，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56095714142, createdName=ms5000000753978789, createdTime=Tue Nov 16 12:24:38 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069348, encodeId=ecc6106934812, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Thu Nov 11 19:41:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068004, encodeId=d0311068004bd, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 08 08:37:43 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
2021-11-16 ms5000000753978789

感谢分享，学习

85 0
[GetPortalCommentsPageByObjectIdResponse(id=1195729, encodeId=28ae1195e292c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d5e6514612, createdName=ms7000001627707414, createdTime=Mon Feb 21 16:24:38 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070730, encodeId=5ad410e073015, content=感谢分享，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56095714142, createdName=ms5000000753978789, createdTime=Tue Nov 16 12:24:38 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069348, encodeId=ecc6106934812, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Thu Nov 11 19:41:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068004, encodeId=d0311068004bd, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 08 08:37:43 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
2021-11-11 ms9000000410256940

学习

76 0
[GetPortalCommentsPageByObjectIdResponse(id=1195729, encodeId=28ae1195e292c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d5e6514612, createdName=ms7000001627707414, createdTime=Mon Feb 21 16:24:38 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070730, encodeId=5ad410e073015, content=感谢分享，学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56095714142, createdName=ms5000000753978789, createdTime=Tue Nov 16 12:24:38 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069348, encodeId=ecc6106934812, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Thu Nov 11 19:41:37 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068004, encodeId=d0311068004bd, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Mon Nov 08 08:37:43 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
2021-11-08 1207866fm50(暂无昵称)

谢谢分享

90 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

英国皮肤科医生协会 2021 年成人基底细胞癌治疗指南

相关指南

拓展阅读

科室

工具

服务